These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7945604)

  • 21. Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
    Hsieh MH; Chen SA; Chiang CE; Tai CT; Lee SH; Wen ZC; Chang MS
    Int J Cardiol; 1996 Apr; 54(1):85-8. PubMed ID: 8792191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 23. Additional causes of torsades de pointes.
    Kelloway JS; Pongowski MA; Schoenwetter WF
    Mayo Clin Proc; 1995 Feb; 70(2):197. PubMed ID: 7845049
    [No Abstract]   [Full Text] [Related]  

  • 24. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythromycin induced torsades de pointes.
    Wong CB; Windle J
    Nebr Med J; 1995 Sep; 80(9):285-6. PubMed ID: 7566254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C; Várkonyi T; Fazekas T
    Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
    JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T wave alternans.
    Drew BJ; Ide B
    Prog Cardiovasc Nurs; 1994; 9(4):45. PubMed ID: 7846007
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration.
    Koh TW
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1575-6. PubMed ID: 11707056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
    Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
    Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of the chronic atrioventricular block cynomolgus monkey as an in vivo model to evaluate drug interaction-associated torsade de pointes.
    Goto A; Sakamoto K; Hagiwara-Nagasawa M; Kambayashi R; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Sugiyama A
    J Pharmacol Sci; 2020 Apr; 142(4):172-175. PubMed ID: 31982331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seventy-four defibrillations for sotalol-induced torsades de pointes.
    Sürücü H; Tatli E; Değirmenci A; Gökmen G
    Indian Heart J; 2004; 56(4):340-2. PubMed ID: 15586745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Torsades de pointes induced by erythromycin.
    Gitler B; Berger LS; Buffa SD
    Chest; 1994 Feb; 105(2):368-72. PubMed ID: 8306730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.
    Batey AJ; Coker SJ
    Br J Pharmacol; 2002 Feb; 135(4):1003-12. PubMed ID: 11861329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication.
    Krähenbühl S; Sauter B; Kupferschmidt H; Krause M; Wyss PA; Meier PJ
    Am J Med Sci; 1995 Jun; 309(6):315-6. PubMed ID: 7771501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
    Eckardt L; Haverkamp W; Mertens H; Johna R; Clague JR; Borggrefe M; Breithardt G
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):425-34. PubMed ID: 9733356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Iatrogenic torsade de pointes induced by thioridazine].
    Paoloni P; Ciliberti D; Blasi N; Capone P
    Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torsades de pointes with terfenadine ingestion.
    June RA; Nasr I
    Am J Emerg Med; 1997 Sep; 15(5):542-3. PubMed ID: 9270401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sotalol-induced torsades de pointes successfully treated with hemodialysis after failure of conventional therapy.
    Singh SN; Lazin A; Cohen A; Johnson M; Fletcher RD
    Am Heart J; 1991 Feb; 121(2 Pt 1):601-2. PubMed ID: 1990770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.